Multiple sclerosis trials in Japan

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  Where

  Higashi-Matsuyama, Kodaira, Kōriyama, Kyoto, Sapporo, Tokyo, Yahaba

  Age

  18 years to 60 years

  People

  160 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07325292 · EU 2026-525688-41-00